Výsledky vyhledávání - "Fr, Appelbaum"

Long-Term Survival after Transplantation of Unrelated Donor Peripheral Blood or Bone Marrow Hematopoietic Cells for Hematologic Malignancy

Autor: Junfang Chen, Claudio Anasetti, Joseph H. Antin, Brent R. Logan, Ryotaro Nakamura, Philip L. McCarthy, Richard T. Maziarz, Mary Eapen, Ravi Vij, FR Appelbaum, Daniel R. Couriel, Voravit Ratanatharathorn, Richard E. Champlin

Publikováno v: Biology of Blood and Marrow Transplantation. 21:55-59

We sought to determine whether differences in chronic graft-versus-host disease (GVHD) rates would lead to survival differences by comparing 2463 peripheral blood (PB) and 1713 bone marrow (BM) hematopoietic cell transplant recipients. Patients had a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68569e55757bb4ac1ea71cdad02210fc
https://doi.org/10.1016/j.bbmt.2014.09.006

Zobrazit plný text záznamu

All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129

Autor: Jae H. Park, Peter H. Wiernik, Martin S. Tallman, Robert E. Gallagher, Elisabeth Paietta, Jacob M. Rowe, James H. Feusner, Cheryl L. Willman, Lois E. Shepherd, Charles A. Schiffer, Dan Douer, FR Appelbaum, Clara D. Bloomfield, Lynette Zickl

Publikováno v: Leukemia Research. 37:795-801

We report a long-term follow-up (median 11.8 years) of the First North American Intergroup Study. 379 patients were randomized to induction with ATRA or to chemotherapy. All complete responders (CR) received consolidation chemotherapy, then randomize

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::958709be7c673cdd074573cbd6d9aa8d
https://doi.org/10.1016/j.leukres.2013.03.001

Zobrazit plný text záznamu

Prognostic factors and outcomes of severe gastrointestinal GVHD after allogeneic hematopoietic cell transplantation

Autor: George B. McDonald, FR Appelbaum, Cristina Castilla-Llorente, Richard A. Nash, Howard M. Shulman, Rainer Storb, H. J. Deeg, Barry E. Storer, P.J. Martin, Marco Mielcarek

Publikováno v: Bone marrow transplantation

We hypothesized that clinical risk factors could be identified within 2 weeks of onset of severe (stage 3 or 4) acute gut GVHD for identifying a patient population with a very poor outcome. Among 1462 patients who had allogeneic hematopoietic cell tr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cac7eeedda39258ddca8010e6751139
https://pubmed.ncbi.nlm.nih.gov/24777184

Zobrazit plný text záznamu

Autor: Barry E. Storer, Jorge Sierra, Jean E. Sanders, Dana C. Matthews, Ann E. Woolfrey, P.J. Martin, FR Appelbaum, Effie W. Petersdorf, Rainer Storb, Claudio Anasetti, John A. Hansen

Publikováno v: Bone Marrow Transplantation. 26:397-404

Between 1985 and 1998, 161 patients with primary acute myeloid leukemia (AML) received T-replete bone marrow transplantation (BMT) from unrelated donors in Seattle. Median age was 30 (range 1–55) years. Conditioning for BMT consisted of cyclophosph

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d592087179d45f66472a1f6165c223b8
https://doi.org/10.1038/sj.bmt.1702519

Zobrazit plný text záznamu

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

Autor: H. J. Deeg, A Fefer, Eileen Bryant, FR Appelbaum, Howard M. Shulman, Claudio Anasetti, Ted Gooley, J E Anderson, John T. Slattery, Rainer Storb

Publikováno v: Blood. 95:1188-1194

We carried out bone marrow transplantation (BMT) in 50 patients with myelodysplastic syndrome (MDS) who were 55.3 to 66.2 years of age (median, 58.8 years). According to the criteria of the French-American-British (FAB) classification, 13 patients ha

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9cd882d5b4d4da4e57301024f04d9f71
https://doi.org/10.1182/blood.v95.4.1188.004k38_1188_1194

Zobrazit plný text záznamu

Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor

Autor: Rainer Storb, Scott D. Rowley, FR Appelbaum, I Majolino, K Lilleby, William I. Bensinger, A M Cavallaro

Publikováno v: Bone Marrow Transplantation. 25:85-89

One hundred and one donors who had received filgrastim (rhG-CSF) for the purpose of donating either granulocytes or peripheral blood stem cells (PBSC) for their relatives more than 3 years ago were contacted. All donors had received daily rhG-CSF at

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::778877e7d75d189383e9085e096bf71a
https://doi.org/10.1038/sj.bmt.1702072

Zobrazit plný text záznamu

Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study

Autor: FR Appelbaum, Thomas R. Chauncey, A York, Stephen H. Petersdorf, John A. Thompson, Oliver W. Press, William I. Bensinger, Nanette Robinson, Catherine G. Lindgren, Buckner Cd, A Fefer, M. Benyunes

Publikováno v: Bone Marrow Transplantation

The success of autologous stem cell transplantation (ASCT) for hematologic malignancy is limited largely by a high relapse rate. It is postulated that IL-2 administered after ASCT may eliminate minimal residual disease and thereby reduce relapses. A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9993e99bdce6cfb8db333f1190040920
http://europepmc.org/articles/PMC7092324

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání